Status:
COMPLETED
Extended Cessation Treatment for Teen Smokers
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)
Conditions:
Nicotine Dependence
Eligibility:
All Genders
14-18 years
Phase:
PHASE2
PHASE3
Brief Summary
This study is designed to test the efficacy of an extended smoking cessation program for teen smokers. We hypothesize that teen smokers randomized to extended treatment will have a higher abstinence r...
Detailed Description
Adolescent smokers (aged 14-18; \> 10 cigarettes/day) attending continuation high schools in the San Francisco-San Jose Bay Area will serve as the target population for this study. 280 smokers meeting...
Eligibility Criteria
Inclusion
- Age 14-18 at the beginning of the study
- Smoking at least 10 cigarettes per day
- At least one quit attempt in previous 6mos
Exclusion
- Current DSM-IV disorder (depression, panic disorder, social anxiety disorder and agoraphobia)
- Current self report of daily or heavy use (more than three times per week) of any drugs (marijuana, alcohol, cocaine, opiates, stimulants, etc.)
- Positive urine pregnancy test
- Currently on bupropion (Wellbutrin, Wellbutrin SR, Zyban) or other antidepressants, MAOI's, antipsychotics, benzodiazepines
- Currently on NRT
- Currently receiving formal treatment for substance abuse problem, depression or anxiety
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT00459953
Start Date
September 1 2006
End Date
July 1 2011
Last Update
May 30 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305